Table 1: Guidelines for red blood cell and plasma transfusion for adults and children [Supplement, CMAJ

Guidelines for red blood cell and plasma transfusion for adults and children

Table 1: Characteristics of red blood cell components depending on anticoagulant used during collection

Characteristic Anticoagulantpreservative solution

CPDA-1 CP2D

Additive (after plasma removed) 0 100 mL AS-3 (Nutricel)

Hematocrit 0.720.79 0.450.65

Red blood cell volume Approx. 200 mL Approx. 200 mL

Plasma volume Approx. 90 mL Approx. 60 mL

Shelf life 35 days 35 days*

Note: CPA-1 = citrate phosphate dextrose adenine; CP2D = citrate phosphate double dextrose.
*Currently licensed by the Bureau of Biologics for 35 days but has the potential for 42 days shelf life. The Canadian Red Cross Society is requesting that the shelf life be extended to 42 days.

[Return to text]

| CMAJ June 1, 1997 (vol 156, no 11) / JAMC le 1er juin 1997 (vol 156, no 11) |

CMA Webspinners / Les fileurs du Web de l'AMC

Table 1: Characteristics of red blood cell components depending on anticoagulant used during collection
Characteristic	Anticoagulantpreservative solution
Characteristic	CPDA-1	CP2D
Additive (after plasma removed)	0	100 mL AS-3 (Nutricel)
Hematocrit	0.720.79	0.450.65
Red blood cell volume	Approx. 200 mL	Approx. 200 mL
Plasma volume	Approx. 90 mL	Approx. 60 mL
Shelf life	35 days	35 days*
Note: CPA-1 = citrate phosphate dextrose adenine; CP2D = citrate phosphate double dextrose. *Currently licensed by the Bureau of Biologics for 35 days but has the potential for 42 days shelf life. The Canadian Red Cross Society is requesting that the shelf life be extended to 42 days.